Reuters logo
BRIEF-Supernus announces settlement with Actavis on Trokendi XR patent litigation
March 7, 2017 / 6:12 PM / in 7 months

BRIEF-Supernus announces settlement with Actavis on Trokendi XR patent litigation

March 7 (Reuters) - Supernus Pharmaceuticals Inc

* Supernus announces settlement with Actavis on Trokendi XR patent litigation

* Patent protection for Trokendi XR expires no earlier than 2027

* Settlement permits Actavis to begin selling generic version of Trokendi XR on Jan 1, 2023, or earlier under certain circumstances Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below